Drug intelligence / Profile preview

OPTIZIOME P³ HYDROLYZER - WHEY

Development stage
Preclinical
Lead developer
BIO-CAT
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Oral
01

Overview

OPTIZIOME P³ HYDROLYZER - WHEY is a proprietary nutritional supplement ingredient developed by BIO-CAT, Inc. It consists of a blend of three microbial protease enzymes (providing 50,000 HUT of fungal proteolytic activity per 250 mg dose) combined with whey protein concentrate. The product is designed to optimize protein digestion by accelerating the breakdown of proteins into absorbable amino acids. Clinical data indicates that co-ingestion with whey protein increases the bioavailability of essential amino acids (EAAs) by 14% and branched-chain amino acids (BCAAs) by 15%. Additionally, it has been shown to influence appetite regulation by reducing ghrelin levels and increasing satiety. It is marketed for use in sports nutrition, healthy aging, and for individuals on GLP-1 medications or recovering from surgery.

Brand names
OPTIZIOME P³ HYDROLYZER - WHEY
Other names
OPTIZIOME P3 HYDROLYZER - WHEYOPTIZIOME P3
02

Targets

GHRL (Ghrelin)

Beyond the preview

Go deeper on OPTIZIOME P³ HYDROLYZER - WHEY.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OPTIZIOME P³ HYDROLYZER - WHEY.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call